Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
mastodon.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
The original server operated by the Mastodon gGmbH non-profit

Administered by:

Server stats:

340K
active users

mastodon.social: AboutStatusProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.4.0-nightly.2025-04-01

#medicine

182 posts128 participants1 post today
Public
NewsFlash

✅ Importance Score: 75 / 100
Nikkei plunge nears 9% as Japanese bank stocks plummetJapan’s Nikkei share average tumbled nearly 9% early on Monday, while an index of Japanese ...
More » newsflash.one/2025/04/06/nikke

News FlashNikkei plunges as Asian markets brace for further tariff fallout; Trump says ‘sometimes you have to take medicine’ – business liveImportance Score: 75 / 100 🔴 Nikkei plunge nears 9% as Japanese bank stocks plummet Japan’s Nikkei share average tumbled nearly 9% early on Monday, while an index of Japanese bank stocks plunged as much as 17%, as concerns over a tariff-induced global recession continue to rip through markets. The Nikkei dropped as much as […]
#News#BreakingNews#LatestNews
Public
MottG

I have started a new weekly newsletter that will be a bibliography of new research articles on the use of automated knowledge discovery in medicine. The bibliography is compiled by a machine learning program developed by Thomas Kirchel, to which I provide manual abstract relevance feedback. You can subscribe to it free by signing up for the newsletter "bims-aukdim Automated knowledge discovery techniques in medicine" at:

biomed.news/reports

Screenshot of part of the first issue of bims-aukdim newsletter on "Automated knowledge discovery techniques in medicine" showing a list of 16 research papers followed by abstracts of each one.
#research#medicine#knowledgeDiscovery
Public
Brittany Trang

The lab's efforts aren't duplicated anywhere, there's no $ to be made so the private sector won't step in, and this lab is key to fighting anti-microbial resistance.

“To me, this is like a blind man with a chainsaw has just gone through the system and arbitrarily cut things without any rationale.”

statnews.com/2025/04/05/cdc-se

STAT · CDC’s top laboratory on sexually transmitted diseases is shut by Trump administrationThe Trump administration fired everyone in a CDC lab that is crucial to tracking drug-resistant gonorrhea and other sexually transmitted diseases. "We are blind," an expert says.
#health#healthcare#publichealth
Public *
Joseph Meyer

A Trend I May Not Like

A few years ago, a very good primary care physician who I had been seeing for decades joined a national chain of medical providers called Village Medical. I have not noticed a drop off in the quality of services. But, there is a less personal feel than what I experienced with private practitioners for most of my life and I am a bit worried about the more distant future of medicine.

This morning, I received an email announcing my dentist is making the same move, joining a national group called High Point Dentistry. The email is written to reassure me: “So what’s changing? Just the name. We’re gaining added support, resources, and dental specialists that will allow us to enhance your experience.” The online ratings of other branches around the country are great. But, I don’t entirely trust online ratings.

Does this amount to a growing capitalist takeover of medicine by the U.S. corporate world? Will the future be more like “trickle down” medicine? Is less administrative work, reduced malpractice risk, or something else the incentive for physicians to join these chains rather than remaining independent? Even if the medical services are okay for now, I worry that may not remain the case after big business has captured a sizable majority of practices and decides to focus more on profit and less on patient care.

#Medicine#Physicians#Doctors
Public
Global News Kingston

Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, Mounjaro
A Canadian scientist has won a 2025 Breakthrough Prize in Life Sciences for discovering a hormone used in diabetes and obesity medications that has changed the lives of millions.
#science #medicine #award #Health #BreakthroughPrize #DrDanielDrucker
globalnews.ca/news/11117783/ca

Public
Global News Guelph

Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, Mounjaro
A Canadian scientist has won a 2025 Breakthrough Prize in Life Sciences for discovering a hormone used in diabetes and obesity medications that has changed the lives of millions.
#science #medicine #award #Health #BreakthroughPrize #DrDanielDrucker
globalnews.ca/news/11117783/ca

Public
Global News Ottawa

Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, Mounjaro
A Canadian scientist has won a 2025 Breakthrough Prize in Life Sciences for discovering a hormone used in diabetes and obesity medications that has changed the lives of millions.
#science #medicine #award #Health #BreakthroughPrize #DrDanielDrucker
globalnews.ca/news/11117783/ca

Public
Global News

Canadian scientist wins Breakthrough Prize for discovery of hormone used in Ozempic, Mounjaro
A Canadian scientist has won a 2025 Breakthrough Prize in Life Sciences for discovering a hormone used in diabetes and obesity medications that has changed the lives of millions.
#science #medicine #award #Health #BreakthroughPrize #DrDanielDrucker
globalnews.ca/news/11117783/ca

ExploreLive feeds
About